CE Marking: Yes

Anika Therapeutics
Monovisc® 1 x 4.0 ml | Arthrosetherapie
Article: Monovisc® 4.0 ml
Manufacturer: Anika Therapeutics
Concentration: HA 22 mg / ml
Package content: 1 x 4.0 ml
Injection range: Pain from knee osteoarthritis
Choose options
Article: Monovisc® 4.0 ml
Manufacturer: Anika Therapeutics
Concentration: HA 22 mg / ml
Package content: 1 x 4.0 ml
Injection range: Pain from knee osteoarthritis
Article: Monovisc® 4.0 ml
Manufacturer: Anika Therapeutics
Concentration: HA 22 mg / ml
Package content: 1 x 4.0 ml
Injection range: Pain from knee osteoarthritis
Monovisc® | Osteoarthritis Therapy
MONOVISC® is a highly effective single-injection therapy for the treatment of pain in knee osteoarthritis. The innovative formulation with state-of-the-art crosslinking technology ensures a long residence time in the joint and provides proven pain relief for at least six months – confirmed by a large, placebo-controlled, randomized, double-blind, multicenter FDA approval study. Thanks to the extremely high hyaluronic acid content (88 mg) in just one injection, MONOVISC® can effectively relieve pain and improve joint mobility.
MONOVISC® – the modern, effective, and safe solution for sustainable pain therapy in knee osteoarthritis.
Osteoarthritis Therapy with Monovisc®
- Single-injection therapy with advanced crosslinking technology
- Very high hyaluronic acid content for long-lasting effects
- Scientifically proven efficacy and safety through FDA approval study
- Biotechnological production via fermentation, free from animal proteins
- Highest purity and sterility for maximum tolerability
- Manufactured in Boston, USA, under the highest quality standards
- Only one injection per therapy cycle
- Fast, long-lasting pain relief and improved joint mobility
- Reduced injection stress and less pain for the patient